US Stock MarketDetailed Quotes
BMRA Biomerica
- 0.640
- -0.066-9.35%
Close Jan 17 16:00 ET
- 0.631
- -0.009-1.47%
Post 20:01 ET
11.74MMarket Cap-1.94P/E (TTM)
0.750High0.602Low11.71MVolume0.710Open0.706Pre Close7.65MTurnover68.37%Turnover RatioLossP/E (Static)18.34MShares1.35052wk High2.29P/B10.96MFloat Cap0.24252wk Low--Dividend TTM17.12MShs Float23.390Historical High--Div YieldTTM20.96%Amplitude0.170Historical Low0.653Avg Price1Lot Size
Biomerica Key Stats
Quarterly+Annual
YOY
| (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.06%-791K | 19.71%-1.34M | 2.06%-5.36M | -8.41%-1.04M | -4.41%-1.8M | 30.59%-842K | -6.42%-1.67M | -1,042.80%-5.47M | 77.37%-963K | -173.15%-1.73M |
| Net income from continuing operations | 36.96%-950K | -16.25%-1.32M | 16.27%-5.98M | 20.70%-1.42M | -16.24%-1.92M | 7.32%-1.51M | 45.37%-1.13M | -57.58%-7.14M | -1.88%-1.79M | -1,483.98%-1.65M |
| Depreciation and amortization | 9.89%100K | 5.43%97K | 6.55%374K | 16.87%97K | 9.30%94K | 5.81%91K | -4.17%92K | -41.01%351K | -72.61%83K | -11.58%86K |
| Change In working capital | -118.05%-89K | 67.02%-219K | -227.96%-389K | -83.42%94K | -321.62%-312K | 532.05%493K | -148.69%-664K | -91.56%304K | 125.27%567K | -103.78%-74K |
| -Change in receivables | -38.11%229K | 12.99%-616K | 26.12%-215K | 141.93%187K | -110.67%-64K | 749.12%370K | -82.47%-708K | -121.32%-291K | -277.29%-446K | 2,406.36%600K |
| -Change in inventory | 119.72%156K | 34.48%429K | -121.54%-115K | -255.56%-224K | -659.46%-281K | 2.90%71K | -10.89%319K | -65.81%534K | -92.25%144K | 89.06%-37K |
| -Change in prepaid assets | -305.36%-115K | 404.76%106K | 210.00%62K | 61.11%29K | 77.78%-44K | -52.54%56K | -74.39%21K | -60.00%20K | -94.81%18K | -146.09%-198K |
| -Change in payables and accrued expense | -505.71%-284K | 71.15%-60K | 761.29%205K | -69.56%207K | 129.63%136K | -32.69%70K | 41.57%-208K | -104.79%-31K | 144.54%680K | -151.51%-459K |
| -Change in other current assets | --6K | --0 | -344.44%-44K | -1,900.00%-18K | -1,000.00%-9K | --0 | -950.00%-17K | -89.35%18K | -98.07%1K | -61.55%1K |
| -Change in other current liabilities | -9.46%-81K | -9.86%-78K | 0.00%-297K | 18.09%-77K | -7.14%-75K | -8.82%-74K | -9.23%-71K | -21.72%-297K | -48.35%-94K | -10.56%-70K |
| -Change in other working capital | ---- | ---- | -95.73%15K | -103.79%-10K | ---- | ---- | ---- | 588.24%351K | 108.35%264K | -91.62%89K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.06%-791K | 19.71%-1.34M | 2.06%-5.36M | -8.41%-1.04M | -4.41%-1.8M | 30.59%-842K | -6.42%-1.67M | -1,042.80%-5.47M | 77.37%-963K | -173.15%-1.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -175.00%-33K | 0 | -47.44%-115K | -71.43%-24K | -166.67%-16K | 50.00%-12K | -85.29%-63K | 54.12%-78K | 41.71%-14K | 68.18%-6K |
| Capital expenditure reported | ---- | ---- | -357.14%-64K | --0 | ---16K | ---- | ---- | ---14K | ---14K | --0 |
| Net PPE purchase and sale | --0 | --0 | 20.31%-51K | ---24K | --0 | 75.00%-6K | 38.24%-21K | -12.28%-64K | --0 | 58.14%-6K |
| Net intangibles purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | ---42K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -175.00%-33K | --0 | -47.44%-115K | -71.43%-24K | -166.67%-16K | 50.00%-12K | -85.29%-63K | 54.12%-78K | 41.71%-14K | 68.18%-6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.86%-81K | -101.10%-81K | 0 | 292.23%9.39M | 19,414.14%7.35M | -96.08%25K | ||||
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 316.90%10.01M | 3,007,418.80%8M | -96.00%26K |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 5.19%81K | -94.71%2K | --0 |
| Net other financing activities | ---- | ---- | 88.51%-81K | ---- | ---- | ---- | ---- | -729.41%-705K | -152,951.64%-652K | 94.27%-1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -100.86%-81K | -101.10%-81K | --0 | ---- | ---- | 292.23%9.39M | 19,414.14%7.35M | -96.08%25K |
| Net cash flow | ||||||||||
| Beginning cash position | -64.70%2.82M | -57.09%4.17M | 64.26%9.72M | 59.01%5.32M | 40.79%7.13M | 31.49%7.99M | 64.26%9.72M | 40.91%5.92M | -67.12%3.35M | -29.62%5.07M |
| Current changes in cash | 48.01%-444K | 22.63%-1.34M | -244.79%-5.56M | -118.03%-1.15M | -6.51%-1.82M | 14.60%-854K | -1,115.79%-1.74M | 120.07%3.84M | 250.19%6.37M | -157.30%-1.71M |
| Effect of exchange rate changes | ---4K | -200.00%-6K | 122.22%8K | --0 | 112.50%2K | --0 | 146.15%6K | -38.46%-36K | 107.63%1K | -530.42%-16K |
| End cash Position | -66.75%2.37M | -64.70%2.82M | -57.09%4.17M | -57.09%4.17M | 59.01%5.32M | 40.79%7.13M | 31.49%7.99M | 64.26%9.72M | 64.26%9.72M | -67.12%3.35M |
| Free cash flow | 3.51%-824K | 22.63%-1.34M | 1.37%-5.48M | -9.31%-1.07M | -4.97%-1.82M | 30.96%-854K | -8.09%-1.74M | -755.47%-5.55M | 77.17%-977K | -173.99%-1.73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
